Association of Androgen Deprivation Therapy With Cardiovascular Death in Patients With Prostate Cancer

2011431 citationsReview

Authors

Paul L. Nguyen · Dana-Farber Cancer Institute

Youjin Je · Harvard University Press

Fabio A.B. Schutz · Harvard University Press

Karen E. Hoffman · Cancer Support Community

Jim C. Hu

Arti Parekh · Harvard University Press

Joshua A. Beckman

Toni K. Choueiri

Abstract

In a pooled analysis of randomized trials in unfavorable-risk prostate cancer, ADT use was not associated with an increased risk of cardiovascular death but was associated with a lower risk of PCSM and all-cause mortality.

Topics & Keywords

Prostate Cancer Treatment and Research Hormonal and reproductive studies Prostate Cancer Diagnosis and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAMA

Volume 306, Issue 21, pp. 2359-66

DOI: 10.1001/jama.2011.1745

Field-Weighted Citation Impact: 32.74